- Surgical treatment for hepatocellular carcinoma with bile duct invasion
-
Hu XG, Mao W, Hong SY, Kim BW, Xu WG, Wang HJ
- KMID: 2155047
- Ann Surg Treat Res.
- 2016 Mar;90(3):139-146.
- doi: 10.4174/astr.2016.90.3.139
PURPOSE: There is still some debate on surgical procedures for hepatocellular carcinoma (HCC) patients with bile duct tumor thrombi (BDTT, Ueda type 3 or 4). What is adequate extent of... -
- CITED
-
- Close
- SHARE
-
- Close
- Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy
-
Hu XG, Mao W, Park YK, Xu WG, Kim BW, Wang HJ
- KMID: 2374155
- Yonsei Med J.
- 2016 Sep;57(5):1115-1123.
- doi: 10.3349/ymj.2016.57.5.1115
PURPOSE: The systemic inflammation biomarker, Neutrophil-to-Lymphocyte Ratio (NLR), has been reported as one of the adverse prognostic factors for hepatocellular carcinoma (HCC) patient. The purpose of this study was to... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells
-
Pei J, Chu T, Shao M, Teng J, Sha H, Gu A, Li R, Qian J, Mao W, Li Y, Han B
- KMID: 2419116
- Yonsei Med J.
- 2017 May;58(3):581-591.
- doi: 10.3349/ymj.2017.58.3.581
PURPOSE: c-Met and its ligand, hepatocyte growth factor (HGF), play a critical role in oncogenesis and metastatic progression. The aim of this study was to identify inhibited enzymogram and to... -
- CITED
-
- Close
- SHARE
-
- Close
